Free Trial

10 Best Small Cap Stocks to Buy Now - 3 of 10

 
 

Quince Therapeutics (NASDAQ:QNCX)

Consensus Rating
Buy
Rating Score
3.4
Ratings Breakdown
5 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
$8.67 (386.9% Upside)

About Quince Therapeutics

Quince Therapeutics logoQuince Therapeutics, Inc, a biopharmaceutical company, focuses on acquiring, developing, and commercializing therapeutics for patients with debilitating and rare diseases. The company's lead asset candidature comprises EryDex for the treatment of rare pediatric neurodegenerative disease, including A-T, an inherited autosomal recessive neurodegenerative and immunodeficiency disorder caused by mutations in ATM gene. Read More 
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
12/18/2024Brookline Capital ManagementInitiated CoverageBuy$9.00
11/7/2024Maxim GroupInitiated CoverageBuy$6.00
10/29/2024RODMAN&RENSHAWUpgradeStrong-Buy
10/29/2024Rodman & RenshawInitiated CoverageBuy$11.00
10/22/2024EF Hutton Acquisition Co. IUpgradeStrong-Buy
 

Cackling Kamala hates this company (Ad)

Do you want to see one of the most exciting election trades of all time? A trade that could help America become 100% energy independent… Reduce energy costs to virtually zero… And hand investors what could be a stunning return in just a few years’ time? It all has to do with a little known company that is helping to kick off the next great American energy revolution.

Before that happens, you need to see the details here.